MedPath

Efficacy of Indomethacin along with standard care of treatment versus standard care of treatment in hospitalized Severe Covid -19 patients

Phase 2
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/08/035567
Lead Sponsor
IIT Madras
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age between 20 to 90 years

RT â?? PCR Positive

Hospitalised patients

dyspnea

A blood oxygen saturation of 93% or less

A ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (Pao2:Fio2) of less than 300 mm Hg, or infiltrates in more than 50% of the lung field

Exclusion Criteria

Hypersensitivity/Allergy to Drug

Gastritis

Recent Heart attack

Severe Asthma

Acute Kidney Injury

Patients with known history of Indomethacin allergy will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath